SNSS Financial Facts
Loss from operations: -9.99MGeneral and administrative: 4M
See Full Income Statement
Total current liabilities: 10.4M
Accumulated deficit: -579.91M
See Full Balance Sheet
Sunesis Pharmaceuticals Inc. (SNSS) Earnings
|
Expand Research on SNSS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +18.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -39.1% | Normal Earnings Time | N/A |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3/7/19 |  |
Q418 | -$0.16 | -$0.21 | +$0.05 | N/A | $270K | N/A |  | | Details |
| 5/8/18 | |
Q118 | -$0.21 | -$0.27 | +$0.06 | $200K | $200K | = | | | Details |
11/2/17  |
|
Q317 | N/A | -$0.37 | N/A | N/A | $220K | = | N/A | N/A | |
| 7/27/17 | Q217 | -$0.41 | -$0.59 | +$0.18 | N/A | $1.43M | = | | | Details | |
| 3/9/17 | |
Q416 | -$0.44 | -$0.43 | -$0.01 | $700K | $600K | = | | | Details |
| 11/3/16 |
|
Q316 | -$0.62 | -$0.71 | +$0.09 | $600K | $600K | N/A | | | Details |
| 7/29/16 |
|
Q216 | -$0.12 | -$0.10 | -$0.02 | $610K | $1.03M | N/A | | | Details |
| 5/5/16 |
|
Q116 | -$0.12 | -$0.12 | $0.00 | $600K | $1K | N/A | | | Details |
